Selected patient samples were representative of various biological and clinical variables such as PAM50 subtype, ploidy, and ER/PR/HER2 status as well as other parameters such as age and tumor size (Figure 1—figure supplement 1B–D). This evidence concerns the gene ERBB2 and neoplasm.